• Nenhum resultado encontrado

Mortality of HIV-infected patients starting antiretroviral therapy in sub-Saharan Africa: comparison with HIV-unrelated mortality.

N/A
N/A
Protected

Academic year: 2017

Share "Mortality of HIV-infected patients starting antiretroviral therapy in sub-Saharan Africa: comparison with HIV-unrelated mortality."

Copied!
10
0
0

Texto

Loading

Imagem

Figure 1 shows estimated all-cause mortality for the year 2004 as the sum of HIV-associated and HIV-free mortality by 5-y age group by country
Figure 1. All-cause mortality for the year 2004 as the total of HIV-related (red area) and HIV-unrelated mortality (white area) by 5-y age group in Coˆte d’Ivoire, Malawi, South Africa, and Zimbabwe
Table 4. Excess mortality per 100 person-years by time period on ART, baseline CD4 count, and clinical stage of disease.

Referências

Documentos relacionados

Here, we will review the epidemiology of the current scenario of cryptococcal meningitis in HIV-infected persons, the strategies to reduce mortality and morbidity due to

The estimates are based on a comparison of the crude death rates obtained using registered mortality, as re- ported to PAHO for the three-year period indicated, and the death

The rapid expansion of ART programmes in settings with weak health systems is associated with high mortality and loss of patients to follow up [19,20]. With the on-going rapid

A retro- spective study was conducted to describe early mortality rates observed in persons diagnosed with incident cases of HIV-associated histoplasmosis admitted in one of the

Although the pathogenesis of HIV infection and the general principles of therapy are the same for HIV-infected adults, adolescents, children and infants, antiretroviral treatment of

Impact of highly active antiretroviral therapy (HAART) on the incidence of opportunistic infections, hospitalizations and mortality among children and adolescents living with

Purpose: To investigate the occurrence of hearing loss in children with HIV and its association with viral load, opportunistic diseases, and antiretroviral treatment.. Methods:

The use of antiretroviral therapy (ART) in these patients reduces the risk of developing active TB [32,33,34], being associated in HIV-infected TB patients with higher rates